European Archives - Page 532 of 1198 - European Medical Journal

Gender Inequality in Cardiology

This week, Jonathan Sackier is joined by Rebecca Dobson, Consultant Cardio-Oncologist at the Heart & Chest Hospital, Liverpool, UK.

Changing Practices and the Impact of New Treatments in Multidisciplinary Cancer Care

A multidisciplinary team (MDT) approach is considered the gold standard for the diagnosis and treatment of cancer. The objectives of this webinar are to: Summarise key changes in MDT practice in the past and the lessons learned and benefits derived from these changes

Eosinophilic Pneumonia Due to Toxocariasis: A Rare Case Report in a Paediatric Patient and Literature Review

Human toxocariasis is a zoonosis caused by the larvae of Toxocara genus parasites. It is usually asymptomatic and self-limiting. However, due to either the direct action of parasites or by immunological mechanisms, it can affect several organs resulting in many clinical manifestations.

GSK and Microsoft tackle Nepal disease transmission

A new disease surveillance project to curb the spread of known and unknown pathogens, especially mosquito-borne illnesses, has been launched by GSK and Microsoft in Nepal.

The leap from medicine to medical affairs

What is it like to switch from medicine to MA, and are we about to see this spike in the wake of COVID-19?

The Greenest Inhaler: A Patient Centric Approach

This EMJ podcast explores the carbon footprint of different inhaler devices and features the expert insight of guest speakers Omar S. Usmani.

Medical affairs, commercial and enhancing soft skills

In this episode, Helena hosts a medical affairs discussion with Novartis UK’s Samin Saeed about leadership, company culture, soft skills development and much more.

EMJ 7.3 2022

Welcome to our third issue of the EMJ flagship for 2023, which focuses on rare diseases. Our team attended the European Conference on Rare Diseases (ECRD) at the end of June, and we are delighted to bring you the highlights from the event. The ECRD saw patients, clinicians, policy makers, and other key stakeholders come together to enable innovation and help drive rare disease policies across Europe.

Tackling Unmet Medical Need: How Slow-Release Intra-articular Corticosteroids Could Play a Role in Improving Quality of Life and Reducing Risk in Osteoarthritis

Osteoarthritis (OA) is the fastest growing cause of disability worldwide, but, with few proven therapeutic options, it is an underserved condition. With increasingly ageing populations contributing to a rising global prevalence, this unmet need only threatens to worsen in the coming years.

Management of Acute and Recurrent Urinary Tract Infections Caused by Resistant Pathogens

At least 60% of females worldwide will experience at least one UTI in their lifetime.4 An array of pathogenic bacteria, both gram-negative and gram-positive, can cause the infections, although in uUTIs, Escherichia coli (E. coli) is the predominant pathogen.